antibodies
Document de presse
2021.10.11
In a new study published in EMBO Journal on October 2, 2021, scientists from the Institut Pasteur, the CNRS, Université de Paris, the Vaccine Research...
Document de presse
2021.10.26
The SARS-CoV-2 virus, responsible for the COVID-19 pandemic, primarily targets the respiratory tract, but its ability to infect cells of the nervous system has...
Document de presse
2021.09.21
The teams from Henri-Mondor AP-HP hospital and Paris-Est Créteil University, Inserm, CNRS, University of Paris, within the Necker-Enfants Malades Institute,...
Document de presse
2021.08.19
Researchers and doctors from the AP-HP, the Institut Pasteur, the University of Paris and the Sorbonne University, have carried out work on the effect of...
Document de presse
2021.05.27
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a...
Document de presse
2021.05.28
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and...
Document de presse
2021.05.12
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed...
News
2020.10.16
Hantaviruses are rodent-borne viruses causing serious zoonotic outbreaks worldwide for which no treatment is available. X-ray structures of the hantavirus...
News
2021.05.03
Free et Self-paced
Emerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several...
News
2020.07.22
Aptamers can be thought of as analogs of antibodies entirely composed of nucleic acids (DNA or RNA). They can be used in a wide range of applications but they...